WHO ACT-Accelerator prioritizes global vaccine approach
The importance of a global approach to vaccine development and production, with a focus on collaboration, was a topic of a technical update and press briefing held 26 June by the WHO.
The usual practices for drug development have been upended by the speed and scale of the Covid-19 pandemic, said officials. “I’m very hopeful and optimistic that this will be an unprecedented collaboration that also sets a model for the future,” said WHO Chief Scientific Officer Soumya Swaminathan, MD, speaking in an update on WHO’s collaborative Access to COVID Tools (ACT) Accelerator project. “Companies that are traditionally rivals are sharing” research protocols and other data and processes usually held as confidential commercial information, said Swaminathan.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.